New Journal Website is available at:

Published by: Shiraz University of Medical Sciences

Sex Difference in Clinical Outcome of Patients With Implantable Cardioverter-defibrillator

Neshat Nazari 1 , * , Sima Sayah 1 , Nasrin Safavi 1 , Mostafa Hekmat 1 and Zahra Emkanjoo 1
Authors Information
1 Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: February 24, 2013, 2 (1); 46-9
  • Published Online: February 24, 2013
  • Article Type: Research Article
  • Received: April 2, 2012
  • Revised: June 12, 2012
  • Accepted: June 21, 2012
  • DOI: 10.5812/cardiovascmed.5027

To Cite: Nazari N, Sayah S, Safavi N, Hekmat M, Emkanjoo Z. et al. Sex Difference in Clinical Outcome of Patients With Implantable Cardioverter-defibrillator, Res Cardiovasc Med. 2013 ;2(1):46-9. doi: 10.5812/cardiovascmed.5027.

Copyright: Copyright © 0, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007; 298(13): 1517-24[DOI][PubMed]
  • 2. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007; 298(13): 1525-32[DOI][PubMed]
  • 3. El-Chami MF, Hanna IR, Bush H, Langberg JJ. Impact of race and gender on cardiac device implantations. Heart Rhythm. 2007; 4(11): 1420-6[DOI][PubMed]
  • 4. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998; 136(2): 205-12[DOI][PubMed]
  • 5. Adams KF, Jr., Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol. 1996; 28(7): 1781-8[DOI]
  • 6. Adams KF, Jr., Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Koch GG, et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation. 1999; 99(14): 1816-21[DOI][PubMed]
  • 7. Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation. 2001; 103(3): 375-80[DOI][PubMed]
  • 8. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006; 114(25): 2766-72[DOI][PubMed]
  • 9. Albert CM, Quigg R, Saba S, Estes NA, 3rd, Shaechter A, Subacius H, et al. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. Am Heart J. 2008; 156(2): 367-72[DOI][PubMed]
  • 10. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm. 2010; 7(7): 876-82[DOI][PubMed]
  • 11. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3): 225-37[DOI][PubMed]
  • 12. Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, et al. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol. 2008; 19(7): 720-4[DOI][PubMed]
  • 13. Haigney MC, Zareba W, Nasir JM, McNitt S, McAdams D, Gentlesk PJ, et al. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm. 2009; 6(2): 180-6[DOI][PubMed]
  • 14. Dolack GL. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial). Cardiac Arrest in Seattle, Conventional versus Amiodarone Drug Evaluation. Am J Cardiol. 1994; 73(4): 237-41[DOI]
  • 15. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol. 2004; 43(12): 2293-9[DOI][PubMed]
  • 16. Russo AM, Day JD, Stolen K, Mullin CM, Doraiswamy V, Lerew DL, et al. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial. J Cardiovasc Electrophysiol. 2009; 20(9): 973-8[DOI][PubMed]
  • 17. Lessmeier TJ, Lehmann MH, Steinman RT, Fromm BS, Akhtar M, Calkins H, et al. Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. Am Heart J. 1994; 128(2): 211-8[DOI]
  • 18. Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005; 16(12): 1265-70[DOI][PubMed]
  • 19. Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Birnie DH. Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death. Europace. 2006; 8(12): 1054-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader